Biogen BIIB
NASDAQ BIIB
$222.82 -3.06 (-1.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biogen (BIIB) Raw Materials (2010 - 2018)

Updated

Biogen's Raw Materials came in at $196.3 million for Q4 2018, up 20.9% from $162.4 million a year earlier.

Analysis

Biogen (BIIB) Raw Materials (2010 - 2018) Analysis & Trends

Going back to Q4 2010, Biogen's Raw Materials data covers 12 quarters.

  • Raw Materials carries a five-year compound annual growth rate of 11.3% (FY2013 to FY2018).
  • Going back by year, Raw Materials was $162.4 million in FY2017 (-4.7%), $170.4 million in FY2016 (-20.0%), $213 million in FY2015 (+66.0%) and $128.3 million in FY2014 (+11.6%).
  • The Q4 2018 figure represents the highest quarterly Raw Materials since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Biogen 33.37 Bn 20.03 Bn 1.96 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 196.30 Mn
Dec 31, 2017 162.40 Mn
Dec 31, 2016 170.40 Mn
Dec 31, 2015 213.00 Mn
Dec 31, 2014 128.30 Mn
Dec 31, 2013 115.00 Mn
Mar 31, 2013 109.80 Mn
Dec 31, 2012 101.80 Mn
Jun 30, 2012 92.90 Mn
Mar 31, 2012 90.80 Mn
Dec 31, 2011 83.80 Mn
Dec 31, 2010 59.00 Mn
API Access

Biogen Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=BIIB&period=max&api_key=YOUR_API_KEY